Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV494
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,284
Award facts
- Contract value 100% obligated
- $15,284.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $15,284.45 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-tablet units). This firm fixed-price contract, which is not set-aside for any specific business type, is scheduled for completion by January 14, 2026, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the comprehensive pharmaceutical supply vehicle for military healthcare systems globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying brand-name and generic medications, vaccines, and medical devices to federal healthcare agencies. The company's extensive federal contracting portfolio demonstrates its capability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government health systems. This delivery order for RINVOQ ER tablets—a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions—exemplifies the routine pharmaceutical procurement activity conducted through DLA's established prime vendor agreements.
Quick answers
Who was awarded contract SPE2DR26FV494?
SPE2DR26FV494 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FV494 worth?
The government has obligated $15,284 on SPE2DR26FV494.
Is contract SPE2DR26FV494 an order under another contract?
Yes. SPE2DR26FV494 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV494 competed?
The extent of competition for SPE2DR26FV494 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award